~~<i id='F5EFAAC76C'><strike id='F5EFAAC76C'><tt id='F5EFAAC76C'><pre id='F5EFAAC76C'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

knowledge

author：focus 2025-10-01 01:53:57 - browse：63

Calling Bullshit course University of Washington — Screenshot via callingbullshit.org

Tired of alternative facts, fake news, and breathless hyperbole, two professors at the University of Washington are trying to strike a blow for science.

Their weapon? A new course: “Calling Bullshit In the Age of Big Data.”

The class website and colorful syllabus went online last month and almost instantly went viral.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Will Ozempic

knowledge

hotspot

focus

hotspot

focus

entertainment

NikolasAlbarranandJoseGomez-MarquezAnewblood testcancheaplyandquicklydistinguishbetweenthemosquito-b

WSS

Lilly's Alzheimer's drug donanemab backed by FDA advisers

The EU Joint Clinical Assessment needs to live up to its promise

Coercive sterilizations revealed by STAT prompt outrage

Hospital price transparency does save money, advocate argues

Pharmacists can make shortage drugs, but at what cost?

Study: Why relieving medical debt did not improve financial outcomes

leisure time

knowledge

knowledge

Affirmative action in medical school literally saved lives

Lilly's Alzheimer's drug donanemab backed by FDA advisers

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Solve the antibiotic resistance crisis with preventive drugs

Apple is now the first public company to be valued at $3 trillion

STAT Readout Newsletter: Today's biggest biotech updates

Trump demands the U.S. pay no more for drugs than other countries … again

Researchers explore possible ties between long Covid, menopause

Wildfire smoke exposes gaps in outdoor worker protections

ALS patient reclaims some autonomy thanks to wearable 'robot'

hotspot

My daughter's legacy lives on through her writing, phage therapy

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Pharmacists can make shortage drugs, but at what cost?

How faith leaders like me can help address America's obesity epidemic

FDA struggles to regulate food additives, sometimes for decades

Lilly's Alzheimer's drug donanemab backed by FDA advisers

focus

hotspot

focus

entertainment